EGFR antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR antibody, covering 2025-05-16 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma [Phase 1, Phase 2]